Background and Aims: PDE4 inhibitors have been attracting attention as new therapeutic agents for chronic airway diseases, it is known to be involved in a wide range of anti-inflammatory and immunomodulatory responses. A pilot study also confirmed that the PDE4 inhibitor inhibited T lymphocyte proliferation. We investigated the PI3K/AKT/mTOR, the MAPK/ERK and the NFAT pathway, which are mainly signaling pathways of T lymphocytes and the mechanism at which stage the PDE4 inhibitor acts.
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Methods: After splenocyte isolation of murine cells, CD4 + T cells were isolated and proliferated with anti-CD3/ CD28 antibodies. After treatment with RNO, Western assay was performed with anti-p-P38, anti-p-JNK1/2, anti-p-ERK1/2, anti NFAT1 (NFATc2) and NF-κB (Ik-Bα, NF-κB p65) antibodies. IP3R1, Calcineurin, NFAT1 and p-PLCγ1 were used for the NFAT1 signal pathway.
Results: IL-2 mRNA and IL-2 cytokine were decreased when treated with RNO in proliferated CD4 + cells. RNO inhibited p-P38 and NFAT1 in Western assay. P-JNK1/2, p-Erk1/2, and p-PI3K tend to increase, Ik-Bα and NF-κB p65 were not show significant changes after RNO treatment. In NFAT1 pathway, RNO inhibited NFAT1, Calcineurin synthesis and did not affect IP3R1 and p-PLCγ1(TCR signals). to severer inflammation. However, the mechanisms of Th17 differentiation is inadequately illustrated and we therefore aimed to research the mechanisms behind in COPD.
Methods:
The level of miR-21, TGF-β/Smad signals, RORγT and the other Th17 related cytokines were detected in lungs of COPD patients and healthy people. Mice COPD models were built with both wild-type and miR-21-/-mice. Inflammatory cells in mice lungs were observed by immunohistochemical staining (IHS). The proportion of Th17 cells in mice spleen lymphocytes were detected by flow cytometry. The primary CD4+ T cells were isolated from mice by magnetic activated cell sorting and treated with cigarette smoke extract, miR-21 mimics or inhibitors respectively, after which, the change of Th17 proportion were observed, along with TGF-β/Smad signals and RORγT.
Results: The level of miR-21, Smad7, p-Smad2, p-Smad3, TGF-β and Th17 related cytokines were increased in lungs of COPD patients. The lung function of model mice were deteriorated along with increased number of RORγT,CD3+, CD4+, and CD68+ cells in lung tissue. And miR-21-/-mice were between the model and the control. The ratio of Th17 cells were increased in model mice spleen lymphocytes. Moreover, the primary CD4 + lymphocytes tended to differentiate into Th17 cells by CSE and miR-21 mimics, and the protein level of RORγT , Smad7, p-Smad2, p-Smad3 and TGF-β were all increased. MiR-21 inhibitors played a reversed role.
Conclusion: These findings demonstrate that Th17 cells were increased in COPD and it might be partly caused by the enhance of miR-21 through the Smad /TGF-β pathway. 
